Gigamed Pharma
Gigamed Pharma, officially known as Gigamed Pharmaceutical Joint Stock Company, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2003, the company has made significant strides in the development and distribution of high-quality pharmaceutical products across major operational regions in Southeast Asia. Specialising in the production of generic medicines, Gigamed Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of therapeutic solutions that cater to various medical needs, setting it apart in a competitive market. With a strong focus on research and development, Gigamed Pharma has achieved notable milestones, solidifying its position as a trusted name in healthcare.
DitchCarbon Score
How does Gigamed Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gigamed Pharma's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Gigamed Pharma's reported carbon emissions
Gigamed Pharma, headquartered in VN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This often includes setting science-based targets for emissions reductions and committing to net-zero goals. However, without specific information from Gigamed Pharma, it is unclear what their particular commitments or strategies may be in addressing climate change and reducing their carbon footprint.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gigamed Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
